Robert Buynak
Internal Medicine · Valparaiso, INNPI 1508977984
Payments from drug & device makers
Across 5,947 payments — averaging $4061.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$9.3M
- Janssen Research & Development, LLC$6.1M
- Boehringer Ingelheim$1M
- Pfizer$920K
- Johnson & Johnson$854K
- Seqirus USA Inc$805K
- plus $5.2M from 22 others
Across 35 payments — averaging $175.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$3K
- GSK$1K
- Gilead$659
- Eli Lilly$535
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 2,567 | $9,321,114 |
| Janssen Research & Development, LLC | 83 | $6,050,434 |
| Boehringer Ingelheim | 69 | $1,046,025 |
| Pfizer | 105 | $919,633 |
| Johnson & Johnson | 46 | $853,830 |
| Seqirus USA Inc | 509 | $805,363 |
| Novo Nordisk AS | 1,007 | $792,861 |
| AstraZeneca | 36 | $756,914 |
| Romark Laboratories, LC | 3 | $732,300 |
| Sanofi Pasteur Inc. | 20 | $488,516 |
| Alnylam Pharmaceuticals Inc. | 1,082 | $460,473 |
| Novavax Inc | 53 | $341,150 |
| Kowa Research Institute, Inc. | 39 | $218,164 |
| GSK | 26 | $211,661 |
| Currax Pharmaceuticals LLC | 29 | $195,885 |
| Eisai Inc. | 28 | $190,202 |
| Eli Lilly | 10 | $172,142 |
| Sanofi US Services Inc. | 28 | $154,089 |
| Novartis | 8 | $113,907 |
| Amgen | 25 | $102,878 |
| Mylan Specialty L.p. | 7 | $47,418 |
| Boehringer Ingelheim International GmbH | 135 | $45,410 |
| Gilead | 16 | $31,220 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30,018 |
| Astrazeneca UK Limited | 2 | $28,590 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $26,576 |
| Verona Pharma, Inc. | 2 | $13,900 |
| Regeneron | 3 | $4,244 |
How this compares
$24,154,919 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Valparaiso
- Crystal TuncayValparaiso$33K
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
- Rita SchmidSouth Bend$599K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.